Aclaris Therapeutics, Inc. Common Shares UNDERWRITING AGREEMENTUnderwriting Agreement • September 25th, 2015 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Introductory. Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [ · ] shares of its common stock, par value $[ · ] per share (the “Shares”). The [ · ] Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional [ · ] Shares as provided in Section 2. The additional [ · ] Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” Jefferies LLC (“Jefferies”) and Citigroup Global Markets Inc. (“Citi”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Shares. To the extent th
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2015 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Employment Agreement”), effective as of, and contingent upon, the effectiveness of the registration statement for the Employer’s initial public offering (“Agreement Effective Date”), is made by and between Aclaris Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Employer”) and Neal Walker (“Executive”).
ASSIGNMENT AGREEMENTAssignment Agreement • September 25th, 2015 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • California
THIS ASSIGNMENT AGREEMENT (the “Agreement”) is made effective as of August 20, 2012 (the “Effective Date”), by and between ACLARIS THERAPEUTICS, INC., a Delaware corporation, having an address of 101 Lindenwood Drive, Suite 400, Malvern, Pennsylvania 19355 (“Assignee”), and MICKEY J MILLER, II, of 5757 Preston View Blvd, Appt. #130, Dallas, Texas 75240, as Personal Representative of the estate of Mickey J. Miller (“Miller Estate”).
